What lies beyond del(5q) in myelodysplastic syndrome?
作者信息
Adema Vera, Bejar Rafael
出版信息
Haematologica. 2013 Dec;98(12):1819-21. doi: 10.3324/haematol.2013.094912.
Abstract
摘要
相似文献
1
What lies beyond del(5q) in myelodysplastic syndrome?骨髓增生异常综合征中5号染色体长臂缺失（del(5q)）之外是什么？
Haematologica. 2013 Dec;98(12):1819-21. doi: 10.3324/haematol.2013.094912.
2
Two different del(5q) clones in a patient with myelodysplastic syndrome.一名骨髓增生异常综合征患者体内的两种不同的5号染色体长臂缺失克隆。
Leuk Lymphoma. 2011 Sep;52(9):1811-4. doi: 10.3109/10428194.2011.575968. Epub 2011 Jun 10.
3
Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.伴有孤立性5号染色体长臂缺失的骨髓增生异常综合征中的克隆进化：基因监测的重要性
Haematologica. 2011 Feb;96(2):177-80. doi: 10.3324/haematol.2010.038281.
4
5
Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.间期荧光原位杂交不能提高骨髓增生异常综合征中 DEL(5q) 和 DEL(20q) 的检出率。
Anticancer Res. 2011 Mar;31(3):1007-10.
6
Images from the Haematologica Atlas of Hematologic Cytology: myelodysplastic syndrome with isolated del(5q).《血液学细胞图谱：伴有孤立性5号染色体长臂缺失的骨髓增生异常综合征》中的图片。
Haematologica. 2022 Oct 1;107(10):2285. doi: 10.3324/haematol.2022.281643.
7
Familial occurrence of myelodysplastic syndrome with del(5q).
Leuk Lymphoma. 2011 Jun;52(6):1143-5. doi: 10.3109/10428194.2011.559669.
8
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.2016年世界卫生组织对“孤立性5号染色体长臂缺失的骨髓增生异常综合征”的修订定义；单一与双重细胞遗传学异常的预后意义
Br J Haematol. 2017 Jul;178(1):57-60. doi: 10.1111/bjh.14636. Epub 2017 Apr 17.
9
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.针对 del(5q) 骨髓增生异常综合征中常见的 25 个髓系疾病相关基因突变的靶向重测序分析。
Haematologica. 2013 Dec;98(12):1856-64. doi: 10.3324/haematol.2013.086686. Epub 2013 Jul 5.
10
Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.在骨髓增生异常综合征伴有5号染色体长臂缺失（del(5q)）的患者中，包括5q-综合征患者，在巨核细胞中观察到5q31缺失。
Genes Chromosomes Cancer. 2000 Dec;29(4):350-2. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1041>3.0.co;2-w.
引用本文的文献
1
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).来那度胺对伴有5号染色体长臂缺失的骨髓增生异常综合征患者的疗效：来自希腊国家骨髓增生异常综合征与再生障碍性贫血综合征登记处（EAKMYS）的真实世界数据。
Cancers (Basel). 2025 Apr 22;17(9):1388. doi: 10.3390/cancers17091388.
2
Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults.儿童、青少年及青年中的罕见血液系统恶性肿瘤和白血病前期病变
Cancers (Basel). 2024 Feb 29;16(5):997. doi: 10.3390/cancers16050997.
3
Myelodysplastic Syndrome: Diagnosis and Screening.骨髓增生异常综合征：诊断与筛查
Diagnostics (Basel). 2022 Jun 29;12(7):1581. doi: 10.3390/diagnostics12071581.
4
5q Deletion Myelodysplastic Syndrome in a Young Male Patient.一名年轻男性患者的5号染色体长臂缺失骨髓增生异常综合征
Cureus. 2021 Aug 26;13(8):e17466. doi: 10.7759/cureus.17466. eCollection 2021 Aug.
5
Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity.来那度胺用于纠正亚洲人种低危del(5q)骨髓增生异常综合征患者的贫血。
Blood Res. 2021 Jun 30;56(2):102-108. doi: 10.5045/br.2021.2021086.
6
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.骨髓增生异常综合征中的核肌醇和肌醇依赖性信号通路。
Cells. 2020 Mar 12;9(3):697. doi: 10.3390/cells9030697.
本文引用的文献
1
Clinical and biological implications of driver mutations in myelodysplastic syndromes.骨髓增生异常综合征中驱动突变的临床和生物学意义。
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12.
2
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.针对 del(5q) 骨髓增生异常综合征中常见的 25 个髓系疾病相关基因突变的靶向重测序分析。
Haematologica. 2013 Dec;98(12):1856-64. doi: 10.3324/haematol.2013.086686. Epub 2013 Jul 5.
3
Molecular genetic testing and the future of clinical genomics.分子遗传学检测与临床基因组学的未来。
Nat Rev Genet. 2013 Jun;14(6):415-26. doi: 10.1038/nrg3493.
4
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.对伴有 del(5q)的骨髓增生异常综合征使用来那度胺的反应：细胞遗传学和突变的影响。
Br J Haematol. 2013 Jul;162(1):74-86. doi: 10.1111/bjh.12354. Epub 2013 Apr 25.
5
Disease-targeted sequencing: a cornerstone in the clinic.疾病靶向测序：临床的基石。
Nat Rev Genet. 2013 Apr;14(4):295-300. doi: 10.1038/nrg3463. Epub 2013 Mar 12.
6
Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.5q 缺失的骨髓增生异常综合征和急性髓系白血病中 17p 缺失和 TP53 突变的发生率。
Genes Chromosomes Cancer. 2012 Dec;51(12):1086-92. doi: 10.1002/gcc.21993. Epub 2012 Aug 30.
7
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.验证低危骨髓增生异常综合征患者的预后模型和突变的影响。
J Clin Oncol. 2012 Sep 20;30(27):3376-82. doi: 10.1200/JCO.2011.40.7379. Epub 2012 Aug 6.
8
Revised international prognostic scoring system for myelodysplastic syndromes.修订版国际预后积分系统用于骨髓增生异常综合征。
Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27.
9
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.重新探讨 5q 髓系恶性肿瘤的解剖学、临床和基因组相关性。
J Clin Oncol. 2012 Apr 20;30(12):1343-9. doi: 10.1200/JCO.2011.36.1824. Epub 2012 Feb 27.
10
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.新的原发性骨髓增生异常综合征（MDS）和 MDS 衍生的少突细胞急性髓系白血病的综合细胞遗传学评分系统，源自国际数据库合并。
J Clin Oncol. 2012 Mar 10;30(8):820-9. doi: 10.1200/JCO.2011.35.6394. Epub 2012 Feb 13.
Zotero 插件